JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression
| Image |  |
|---|---|
| Description | scientific article published on 18 August 2019 |
| Author/s |
author: James R Berenson Eric Sanchez |
| Publication date | August 18, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |